These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

571 related articles for article (PubMed ID: 19817893)

  • 1. CD10+ fibroblasts are more involved in the progression of hilar/extrahepatic cholangiocarcinoma than of peripheral intrahepatic cholangiocarcinoma.
    Nishihara Y; Aishima S; Hayashi A; Iguchi T; Fujita N; Taketomi A; Honda H; Tsuneyoshi M
    Histopathology; 2009 Oct; 55(4):423-31. PubMed ID: 19817893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metallothionein overexpression and its prognostic relevance in intrahepatic cholangiocarcinoma and extrahepatic hilar cholangiocarcinoma (Klatskin tumors).
    Schmitz KJ; Lang H; Kaiser G; Wohlschlaeger J; Sotiropoulos GC; Baba HA; Jasani B; Schmid KW
    Hum Pathol; 2009 Dec; 40(12):1706-14. PubMed ID: 19683330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Down-regulation of aquaporin-1 in intrahepatic cholangiocarcinoma is related to tumor progression and mucin expression.
    Aishima S; Kuroda Y; Nishihara Y; Taguchi K; Iguchi T; Taketomi A; Maehara Y; Tsuneyoshi M
    Hum Pathol; 2007 Dec; 38(12):1819-25. PubMed ID: 17854859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extrahepatic cholangiocarcinoma: current surgical strategy.
    Boutros C; Somasundar P; Espat NJ
    Surg Oncol Clin N Am; 2009 Apr; 18(2):269-88, viii. PubMed ID: 19306812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proposal of progression model for intrahepatic cholangiocarcinoma: clinicopathologic differences between hilar type and peripheral type.
    Aishima S; Kuroda Y; Nishihara Y; Iguchi T; Taguchi K; Taketomi A; Maehara Y; Tsuneyoshi M
    Am J Surg Pathol; 2007 Jul; 31(7):1059-67. PubMed ID: 17592273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenotypic diversity of intrahepatic and extrahepatic cholangiocarcinoma on aspiration cytology and core needle biopsy: case series and review of the literature.
    Chaudhary HB; Bhanot P; Logroño R
    Cancer; 2005 Aug; 105(4):220-8. PubMed ID: 15952192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Left hemihepatectomy and caudate lobectomy and complete extrahepatic bile duct resection using transduodenal approach for hilar cholangiocarcinoma arsing from biliary papillomatosis.
    Kim JK; Hwang HK; Park JS; Cho SI; Yoon DS; Chi HS
    J Surg Oncol; 2008 Aug; 98(2):139-42. PubMed ID: 18521837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aggressive surgical resection for hilar-invasive and peripheral intrahepatic cholangiocarcinoma.
    Nakagohri T; Asano T; Kinoshita H; Kenmochi T; Urashima T; Miura F; Ochiai T
    World J Surg; 2003 Mar; 27(3):289-93. PubMed ID: 12607053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prognostic factors and long term outcome after surgery for hilar cholangiocarcinoma. Univariate and multivariate analysis].
    Ramacciato G; Di Benedetto F; Cautero N; Masetti M; Mercantini P; Corigliano N; Nigri G; Lauro A; Ercolani G; Del Gaudio M; De Ruvo N; Pinna AD
    Chir Ital; 2004; 56(6):749-59. PubMed ID: 15771027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carcinoma of the extrahepatic bile duct: mode of spread and its prognostic implications.
    Yamaguchi K; Chijiiwa K; Saiki S; Shimizu S; Takashima M; Tanaka M
    Hepatogastroenterology; 1997; 44(17):1256-61. PubMed ID: 9356836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The clinical presentation and prognostic factors for intrahepatic and extrahepatic cholangiocarcinoma in a tertiary care centre.
    Singal AG; Rakoski MO; Salgia R; Pelletier S; Welling TH; Fontana RJ; Lok AS; Marrero JA
    Aliment Pharmacol Ther; 2010 Mar; 31(6):625-33. PubMed ID: 20003093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The current management of hilar cholangiocarcinoma.
    Jarnagin WR; Fong Y; Blumgart LH
    Adv Surg; 1999; 33():345-73. PubMed ID: 10572576
    [No Abstract]   [Full Text] [Related]  

  • 13. Expression of matrix metalloproteinase 7 is an unfavorable postoperative prognostic factor in cholangiocarcinoma of the perihilar, hilar, and extrahepatic bile ducts.
    Itatsu K; Zen Y; Yamaguchi J; Ohira S; Ishikawa A; Ikeda H; Sato Y; Harada K; Sasaki M; Sasaki M; Sakamoto H; Nagino M; Nimura Y; Ohta T; Nakanuma Y
    Hum Pathol; 2008 May; 39(5):710-9. PubMed ID: 18329694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pathology of cholangiocarcinoma].
    Guedj N; Bedossa P; Paradis V
    Ann Pathol; 2010 Dec; 30(6):455-63. PubMed ID: 21167432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The concept of perihilar cholangiocarcinoma is valid.
    Ebata T; Kamiya J; Nishio H; Nagasaka T; Nimura Y; Nagino M
    Br J Surg; 2009 Aug; 96(8):926-34. PubMed ID: 19591162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fascin overexpression is involved in carcinogenesis and prognosis of human intrahepatic cholangiocarcinoma: immunohistochemical and molecular analysis.
    Iguchi T; Aishima S; Taketomi A; Nishihara Y; Fujita N; Sanefuji K; Sugimachi K; Yamashita Y; Maehara Y; Tsuneyoshi M
    Hum Pathol; 2009 Feb; 40(2):174-80. PubMed ID: 18835624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [An analysis on prognostic factors of hilar cholangiocarcinoma].
    Zhou LX; Zhang ZW; Xu ZY
    Zhonghua Yi Xue Za Zhi; 2009 May; 89(18):1275-7. PubMed ID: 19595185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognosis and treatment of bile duct carcinoma.
    Chung C; Bautista N; O'Connell TX
    Am Surg; 1998 Oct; 64(10):921-5. PubMed ID: 9764692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell adhesion molecules P-cadherin and CD24 are markers for carcinoma and dysplasia in the biliary tract.
    Riener MO; Vogetseder A; Pestalozzi BC; Clavien PA; Probst-Hensch N; Kristiansen G; Jochum W
    Hum Pathol; 2010 Nov; 41(11):1558-65. PubMed ID: 20621328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic factors of intrahepatic cholangiocarcinoma after hepatic resection: univariate and multivariate analysis.
    Hanazaki K; Kajikawa S; Shimozawa N; Shimada K; Hiraguri M; Koide N; Adachi W; Amano J
    Hepatogastroenterology; 2002; 49(44):311-6. PubMed ID: 11995440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.